Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032

Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032



The global virtual clinical trials market size is expected to reach USD 28,544.08 million by 2032, according to a new study by Polaris Market Research. The report “Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increased research and development activities, healthcare digitization, and the adoption of telehealth drive the virtual clinical trials market. These factors enable seamless integration of virtual trials, remote participation, and monitoring in clinical studies. Collaborations between organizations and supportive government initiatives contribute to the market's growth. These trends emphasize the industry's focus on virtual methods, which offer flexibility, efficiency, and improved patient engagement in clinical trials.

The COVID-19 pandemic has profoundly impacted clinical trials, leading to increased adoption of virtual trials. Challenges in patient recruitment and retention have been observed, and disruptions to ongoing trials have occurred. Virtual trials emerged as a crucial solution during the pandemic, allowing participants to participate from home and ensuring research continuity when site visits were impossible.

Virtual trials offer numerous advantages, including remote data collection, increased participant engagement, and larger population inclusion. They minimize risks associated with in-person visits and reduce the burden on participants, coordinators, and investigators. By leveraging virtual methods, the clinical trials industry can overcome challenges, improve efficiency, and facilitate prompt and effective data collection.

Virtual Clinical Trials Market Report Highlights

The interventional design segment dominated the market in 2022, driven by the need for innovative medications and the increased demand for trials amidst the COVID-19 pandemic.

The oncology segment led the market in 2022 and is expected to maintain its dominance due to the rising incidence of cancer and the adoption of virtual trials for patient safety during the COVID-19 pandemic.

North America holds a significant revenue share in the global virtual clinical trials market, driven by major pharmaceutical companies, government investments, and collaborations like Janssen and PRA Health Sciences' decentralized Canagliflozin study for heart failure patients.

The global key market players include LEO Innovation Lab, Covance Inc., CRF Health, Oracle Corporation, Medable, Inc., Paraxel International, Clinical Ink, Inc., PRA Health Sciences, Science 37, and ICON plc.

Polaris Market Research has segmented the Virtual Clinical Trials market report based on design, indication, phases, and region:

Virtual Clinical Trials, Design Outlook (Revenue - USD Million, 2019 - 2032)

Observational Trials

Interventional Trials

Expanded Access Trials

Virtual Clinical Trials, Indication Outlook (Revenue - USD Million, 2019 - 2032)

CNS

Autoimmune/Inflammation

Cardiovascular Disease

Metabolic/Endocrinology

Infectious Disease

Oncology

Genitourinary

Ophthalmology

Virtual Clinical Trials, Phases Outlook (Revenue - USD Million, 2019 - 2032)

Phase I

Phase II

Phase III

Phase IV

Virtual Clinical Trials, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Virtual Clinical Trials Market Insights
4.1. Virtual Clinical Trials Market – Phases Snapshot
4.2. Virtual Clinical Trials Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Advancements in Technology
4.2.1.2. Researchers to access a more diverse and global patient population
4.2.2. Restraints and Challenges
4.2.2.1. Data Security and Privacy Concerns
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Virtual Clinical Trials Market Phases Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Virtual Clinical Trials Market, by Design
5.1. Key Findings
5.2. Introduction
5.2.1. Global Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
5.3. Observational Trials
5.3.1. Global Virtual Clinical Trials Market, by Observational Trials, by Region, 2019-2032 (USD Million)
5.4. Interventional Trials
5.4.1. Global Virtual Clinical Trials Market, by Interventional Trials, by Region, 2019-2032 (USD Million)
5.5. Expanded Access Trials
5.5.1. Global Virtual Clinical Trials Market, by Expanded Access Trials, by Region, 2019-2032 (USD Million)
6. Global Virtual Clinical Trials Market, by Indication
6.1. Key Findings
6.2. Introduction
6.2.1. Global Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
6.3. CNS
6.3.1. Global Virtual Clinical Trials Market, by CNS, by Region, 2019-2032 (USD Million)
6.4. Autoimmune/Inflammation
6.4.1. Global Virtual Clinical Trials Market, by Autoimmune/Inflammation, by Region, 2019-2032 (USD Million)
6.5. Cardiovascular Disease
6.5.1. Global Virtual Clinical Trials Market, by Cardiovascular Disease, by Region, 2019-2032 (USD Million)
6.6. Metabolic/Endocrinology
6.6.1. Global Virtual Clinical Trials Market, by Metabolic/Endocrinology, by Region, 2019-2032 (USD Million)
6.7. Infectious Disease
6.7.1. Global Virtual Clinical Trials Market, by Infectious Disease, by Region, 2019-2032 (USD Million)
6.8. Oncology
6.8.1. Global Virtual Clinical Trials Market, by Oncology, by Region, 2019-2032 (USD Million)
6.9. Genitourinary
6.9.1. Global Virtual Clinical Trials Market, by Genitourinary, by Region, 2019-2032 (USD Million)
6.10. Ophthalmology
6.10.1. Global Virtual Clinical Trials Market, by Ophthalmology, by Region, 2019-2032 (USD Million)
7. Global Virtual Clinical Trials Market, by Phases
7.1. Key Findings
7.2. Introduction
7.2.1. Global Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
7.3. Phase I
7.3.1. Global Virtual Clinical Trials Market, by Phase I, By Region, 2019-2032 (USD Million)
7.4. Phase II
7.4.1. Global Virtual Clinical Trials Market, by Phase II, By Region, 2019-2032 (USD Million)
7.5. Phase III
7.5.1. Global Virtual Clinical Trials Market, by Phase III, By Region, 2019-2032 (USD Million)
7.6. Phase IV
7.6.1. Global Virtual Clinical Trials Market, by Phase IV, By Region, 2019-2032 (USD Million)
8. Global Virtual Clinical Trials Market, by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Virtual Clinical Trials Market Assessment, By Geography, 2019-2032 (USD Million)
8.3. Virtual Clinical Trials Market – North America
8.3.1. North America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.3.2. North America: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.3.3. North America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.3.4. Virtual Clinical Trials Market – U.S.
8.3.4.1. U.S.: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.3.4.2. U.S.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.3.4.3. U.S.: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.3.5. Virtual Clinical Trials Market – Canada
8.3.5.1. Canada: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.3.5.2. Canada.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.3.5.3. Canada: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.4. Virtual Clinical Trials Market – Europe
8.4.1. Europe: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.4.2. Europe.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.4.3. Europe: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.4.4. Virtual Clinical Trials Market – UK
8.4.4.1. UK: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.4.4.2. UK.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.4.4.3. UK: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.4.5. Virtual Clinical Trials Market – France
8.4.5.1. France: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.4.5.2. France.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.4.5.3. France: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.4.6. Virtual Clinical Trials Market – Germany
8.4.6.1. Germany: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.4.6.2. Germany.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.4.6.3. Germany: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.4.7. Virtual Clinical Trials Market – Italy
8.4.7.1. Italy: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.4.7.2. Italy.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.4.7.3. Italy: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.4.8. Virtual Clinical Trials Market – Spain
8.4.8.1. Spain: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.4.8.2. Spain.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.4.8.3. Spain: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.4.9. Virtual Clinical Trials Market – Netherlands
8.4.9.1. Netherlands: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.4.9.2. Netherlands.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.4.9.3. Netherlands: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.4.10. Virtual Clinical Trials Market – Russia
8.4.10.1. Russia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.4.10.2. Russia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.4.10.3. Russia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.5. Virtual Clinical Trials Market – Asia Pacific
8.5.1. Asia Pacific: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.5.2. Asia Pacific.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.5.3. Asia Pacific: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.5.4. Virtual Clinical Trials Market – China
8.5.4.1. China: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.5.4.2. China.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.5.4.3. China: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.5.5. Virtual Clinical Trials Market – India
8.5.5.1. India: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.5.5.2. India.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.5.5.3. India: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.5.6. Virtual Clinical Trials Market – Malaysia
8.5.6.1. Malaysia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.5.6.2. Malaysia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.5.6.3. Malaysia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.5.7. Virtual Clinical Trials Market – Japan
8.5.7.1. Japan: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.5.7.2. Japan.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.5.7.3. Japan: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.5.8. Virtual Clinical Trials Market – Indonesia
8.5.8.1. Indonesia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.5.8.2. Indonesia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.5.8.3. Indonesia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.5.9. Virtual Clinical Trials Market – South Korea
8.5.9.1. South Korea: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.5.9.2. South Korea.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.5.9.3. South Korea: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.6. Virtual Clinical Trials Market – Middle East & Africa
8.6.1. Middle East & Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.6.2. Middle East & Africa.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.6.3. Middle East & Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.6.4. Virtual Clinical Trials Market – Saudi Arabia
8.6.4.1. Saudi Arabia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.6.4.2. Saudi Arabia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.6.4.3. Saudi Arabia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.6.5. Virtual Clinical Trials Market – UAE
8.6.5.1. UAE: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.6.5.2. UAE.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.6.5.3. UAE: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.6.6. Virtual Clinical Trials Market – Israel
8.6.6.1. Israel: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.6.6.2. Israel.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.6.6.3. Israel: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.6.7. Virtual Clinical Trials Market – South Africa
8.6.7.1. South Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.6.7.2. South Africa.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.6.7.3. South Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.7. Virtual Clinical Trials Market – Latin America
8.7.1. Latin America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.7.2. Latin America.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.7.3. Latin America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.7.4. Virtual Clinical Trials Market – Mexico
8.7.4.1. Mexico: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.7.4.2. Mexico.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.7.4.3. Mexico: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.7.5. Virtual Clinical Trials Market – Brazil
8.7.5.1. Brazil: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.7.5.2. Brazil.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.7.5.3. Brazil: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
8.7.6. Virtual Clinical Trials Market – Argentina
8.7.6.1. Argentina: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
8.7.6.2. Argentina.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
8.7.6.3. Argentina: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. LEO Innovation Lab
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Covance Inc
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. CRF Health
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Oracle Corporation
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Medable, Inc
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Paraxel International
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Clinical Ink, Inc
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. PRA Health Sciences
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Science 37
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. ICON plc
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings